FcRn-targeting and ROS-responsive Fedratinib-incorporated nanoparticles alleviate asthma by inducing eosinophil apoptosis

Allergy. 2023 Jun;78(6):1659-1663. doi: 10.1111/all.15575. Epub 2022 Nov 20.

Authors

Weimin Sun^{1

2}, Shijie Song¹, Guangmeng Li¹, Linghui Zhou¹, Junmou Xie¹, Yuhe Guo¹, Jun Zeng¹, Junyan Zhang¹, Linmei Li¹, Ying He¹, Jie Yan¹, Xintao Shuai^{1

3

4}, Ailin Tao¹

Affiliations

¹ The Second Affiliated Hospital, The State Key Laboratory of Respiratory Disease, Guangdong Provincial Key Laboratory of Allergy & Clinical Immunology, Guangzhou Medical University, Guangzhou, China.
² Department of Laboratory Medicine, The Seventh Affiliated Hospital of Southern Medical University, Foshan, China.
³ Department of Gastrointestinal Surgery, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
⁴ PCFM Lab of Ministry of Education, School of Materials Science and Engineering, Sun Yat-sen University, Guangzhou, China.

PMID: 36325826
DOI: 10.1111/all.15575

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Apoptosis
Asthma* / drug therapy
Eosinophils
Humans
Nanoparticles*
Reactive Oxygen Species

Substances

Reactive Oxygen Species